Multiple Sclerosis | News | Blogs | Updates | 2023
Roche reported the Phase II FENopta study of fenebrutinib in adult patients with relapsing forms of multiple sclerosis (RMC). The drug...
top of page
Women Health | Menopause News | iPharmaCenter
The US Food and Drug Administration approved Astellas Pharma's Veozah (lasofoxifene) for treating moderate to severe hot flashes...
Meningococcal infection | iPharmaCenter
GlaxoSmithKline (GSK) has presented positive results from the phase III trial of its MenABCWY vaccine candidate at the European Society...
Top pharmaceutical companies by revenues in 2023 | Big Pharma | iPharmaCenter
TOP PHARMACEUTICAL COMPANIES BY REVENUES 2023 JOHNSON AND JOHNSON Q1 REVENUES Johnson and Johnson reported Q1 revenues for 2023. The...
China Drug Approvals | 2022 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenter
Takeda announced that the National Medical Products Administration (NMPA) of China approved Exkivity (mobocertinib) for treating adults...
Deals and Acquisitions | 2023 | Pharma | News | Healthcare | iPharmaCenter
Merck announced that it had entered an agreement to acquire Prometheus Biosciences. Merck aims to strengthen its immunology portfolio...
Pharmaceutical Companies Deals and acquisitions | Sanofi | Amgen | Pfizer | 2022 | iPharmaCenter
December 12, 2022 After Sanofi failed to acquire, Amgen announced its plan to acquire Horizon Therapeutics. Amgen announced that it has...
HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter
Find the latest healthcare and pharmaceutical news of France | HAS assessment outcomes and drug approvals in France of 2023
How is AbbVie bracing for the impact of Humira’s biosimilars? | iPharmaCenter
AbbVie’s multibillion blockbuster Humira has been the best-selling product in the industry for several years. It generated $21.2 billion...
TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022
REVENUES OF TOP BIOPHARMACEUTICAL COMPANIES - 2022 1 CHF = 1.01 USD, 1 GBP = 1.16USD; 1EUR= 0.99 USD; 1DKK = 0.13 USD; 1 JPY = 0.0075 USD...
2022 FDA Drug Approvals | US Pharma News | iPharmaCenter
December 23, 2022 FDA approved Lunsumio, Roche's bispecific antibody, for follicular lymphoma Roche announced that its bispecific...
Top-selling cancer drugs | 2022 | 2023 | Best cancer products | iPharmaCenter
1. Keytruda Revenues: $20.9 billion Indications: Advanced non-small cell lung cancer, melanoma, head and neck squamous cell cancer,...
Top 5 drug launches in 2023 that has potential to be blockbusters | iPharmaCenter
FIVE DRUG LAUNCHES IN 2023 THAT HAS POTENTIAL TO BECOME BLOCKBUSTERS Peak revenues are collected from different sources SRP-9001 Patients...
Expected best selling drugs of 2023
ANTICIPATED/EXPECTED BEST SELLING PRODUCTS OF 2023 CLICK HERE TO CHECK TOP PHARMACEUTICALS BY REVENUES IN 2023 Evaluate has published the...
Access to Medicines | 2021 | 2022 | News | iPharmaCenter | GSK tops list
GSK maintains the top place in the Access to Medicines rating in 2022; J&J and AZ followed the list The 2022 Access to Medicine Index was...
Multiple Myeloma | News | Blogs | FDA and EMA approvals | Updates on clinical guidelines
November 07, 2022 Blenrep failed to demonstrate superior PFS versus PomDex in RRMM patients GSK announced that Blenrep (belantamab...
Merck and Moderna agreed to develop and commercialize a cancer vaccine | iPharmaCenter
Merck and Moderna have announced that Merck has exercised its option to collaborate and commercialize the cancer vaccine. The companies...
Sanofi gave a statement on the U.S. Zantac litigation | iPharmaCenter
Sanofi issued a position statement on the U.S. Zantac litigation. On September 12, 2019, FDA stated that ranitidine-containing medicines,...
AbbVie's JAK inhibitor, Rinvoq, was approved for UC and nr-axSpA in Europe | iPharmaCenter
AbbVie announced that its Janus Kinase (JAK) inhibitor was approved by the European Commission for non-radiographic axial...
Top 20 healthcare companies | iPharmaCenter | Top healthcare companies by revenues
Fortune has published the list of top 500 companies, and here is the list of top 20 health care companies. CVS Health CVS Health is an...
Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter
Merck has announced the results of two Phase 3 trials of Keytruda - in combination with Lenvima in unresectable hepatocellular carcinoma...
Expected best selling pharmaceuticals/drugs of 2022
EXPECTED BEST SELLING PRODUCTS OF 2022 Comirnaty (Pfizer) Comirnaty is a messenger RNA (mRNA) based COVID vaccine developed by Pfizer and...
Health Canada Drug Approvals | Healthcare and Pharmaceutical News of Canada | News | Blogs | Canada
Health Canada approved Rybrevant for EGFR exon insertion mutation NSCLC. Janssen announced that Health Canada issued a Notice of...
Top pharmaceutical companies by revenues in 2021 | Top 10 pharma companies | iPharmaCenter
TOP BIOPHARMACEUTICAL COMPANIES BY REVENUES IN 2021 Revenues in billions Also read: Italy healthcare system 1. JOHNSON AND JOHNSON Q1...
Australia Drug Approvals | Drugs approved by TGA
September 30, 2022 TGA approved Moderna bivalent vaccine as a booster dose. The Therapeutic Good Administration granted provisional...
Collaborations for drug development in Pharma and Healthcare |
Exscientia and Sanofi collaborated to develop AI-driven pipeline medicines, UK based drug discovery companies may receive payments up to...
COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine
December 21, 2022 Sanofi and GSK's VidPrevtyn Beta COVID-19 booster vaccine approved in Great Britain. GSK and Sanofi announced that the...
COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
India started vaccination of adolescents; Bharat Biotech says Covaxin demonstrated robust efficacy and safety in people of age 2-18 years...
Top 20 pharmaceutical companies by revenues in 2020
PHARMACEUTICAL COMPANIES BY REVENUES IN 202O Also check: Top pharmaceutical companies by revenues in 2021 The other big biopharmaceutical...
FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK
Pfizer has announced that the Food and Drug Administration approved Paxlovid (nirmatrelvir tablets and ritonavir tablets) to treat...
~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio
Novartis announced that the US FDA approved Leqvio (inclisiran) to decrease the lower low-density lipoprotein cholesterol (bad...
Myasthenia Gravis News | FDA and EMA approvals |
FDA approved Vyvgart for Myasthenia Gravis FDA announced that it had approved Vyvgart (efgartigimod) for generalized myasthenia gravis...
Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News
December 2021 IQWIG says Rinvoq has added benefit at higher doses, but with safety issues IQWIG has assessed the benefit assessment of...
China released the 2022 NDRL list, Chinese pharma benefited from the list
China has released the 2021 Drug catalog, which included 2,860 drugs, out of which 1,486 drugs are Western drugs. Reuters reported a...
PBAC News Updates
21 November 2021 Australia included Takhzyro in PBS scheme Australia included Takhzyro (lanadelumab) in the Pharmaceutical Benefits...
European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19
Ronapreve (casirivimab / imdevimab) approved for treating and preventing COVID19 in adults and adolescents Celltrion's Regkirona...
American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
ABBVIE RINVOQ AbbVie presented the Phase 3 SELECT-PsA 1 and SELECT-PsA 2 data of Rinvoq in patients with psoriatic arthritis. Rinvoq...
Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
The U.N. agency World Health Organisation (WHO) had made a statement on the next WHO chief. WHO announced that the member states proposed...
WHO granted EUL to Covaxin; acclaims easy storage requirement
WHO has announced that it has granted emergency use listing for Covaxin developed by Bharat Biotech. This adds another vaccine to the...
FDA approved Novartis Scembli for chronic myeloid leukemia
Novartis announced that the US FDA had approved Scemblix (asciminib) for treating patients with chronic myeloid leukemia. Scemblix...
Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval
The US FDA approved Biogen's Aduhelm (aducanumab) for Alzheimer's disease. It is the first approved product for AD since 2003 and acts by...